AxoGen Inc expected to post a loss of 10 cents a share - Earnings Preview
01/03/2024 14:00
* AxoGen Inc AXGN.OQ AXGN.O is expected to show a rise
in
quarterly revenue when it reports results on March 5 for the
period ending December 31 2023
* The Alachua Florida-based company is expected to report a
15.2% increase in revenue to $41.649 million from $36.16 million
a year ago, according to the mean estimate from 6 analysts,
based on LSEG data.The company's guidance on January 4 2024, for
the period ended December 31, was for revenue of $42.700
million.
* LSEG's mean analyst estimate for AxoGen Inc is for a loss
of 10
cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for AxoGen Inc
is
$11.50, above its last closing price of $10.56.
The company's guidance on June 7 2023 for the period ended
December 31 was for gross profit margin of USD80%.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Sep. 30 2023 -0.05 -0.06 0.01 Beat 116
Jun. 30 2023 -0.11 -0.13 -0.03 Beat 76.9
Mar. 31 2023 -0.15 -0.14 -0.10 Beat 31
Dec. 31 2022 -0.11 -0.11 -0.03 Beat 73.6
Sep. -0.13 -0.12 -0.01 Beat 91.8
30 2022
Jun. 30 2022 -0.14 -0.14 -0.06 Beat 58.6
Mar. 31 2022 -0.16 -0.15 -0.20 Missed -30.4
Dec. 31 2021 -0.12 -0.13 -0.08 Beat 39.1
This summary was machine generated March 1 at 14:00 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)